David J. Taylor
Suspicious Timing Detected
5 flagsRep. David J. Taylor bought $1,001 - $15,000 in $PG on January 9, 2026, 5 days before HR7050, the "Homeopathic Drug Product Safety, Quality, and Transparency Act," which could impact consumer goods companies.
Rep. David J. Taylor bought $1,001 - $15,000 in $PG on January 9, 2026, 6 days before S3677, the "Dietary Supplement Listing Act of 2026," which mandates pre-market listing for dietary supplements.
Rep. David J. Taylor bought $15,001 - $50,000 in $IBM on January 8, 2026, 32 days before S3809, the "AI Grand Challenges Act of 2026," which authorizes the National Science Foundation.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $IBM | International Business Machines Corporation Common Stock | $15K-$50K | — | — | — | Jan 8, 2026 |
| BUY | $IBM | International Business Machines Corporation Common Stock | $1K-$15K | — | — | — | Jan 8, 2026 |
| BUY | $MSFT | Microsoft Corporation - Common Stock | $1K-$15K | — | — | — | Jan 8, 2026 |
| BUY | $MSFT | Microsoft Corporation - Common Stock | $1K-$15K | — | — | — | Jan 8, 2026 |
| BUY | $PG | Procter & Gamble Company | $1K-$15K | — | — | — | Jan 9, 2026 |
| SELL | $LRCX | Lam Research Corporation - Common Stock | $15K-$50K | — | — | — | Jan 8, 2026 |
| SELL | $LRCX | Lam Research Corporation - Common Stock | $15K-$50K | — | — | — | Jan 8, 2026 |
| SELL | $AVGO | Broadcom Inc. - Common Stock | $1K-$15K | — | — | — | Jan 8, 2026 |
| SELL | $AVGO | Broadcom Inc. - Common Stock | $1K-$15K | — | — | — | Jan 8, 2026 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Homeopathic Drug Product Safety, Quality, and Transparency Act
The Homeopathic Drug Product Safety, Quality, and Transparency Act introduces stringent FDA oversight for homeopathic products, effectively reclassifying them as drugs requiring pre-market approval. This eliminates the current regulatory loophole benefiting manufacturers, leading to significant compliance costs and market contraction for companies currently selling these products.
A bill to support National Science Foundation education and professional development relating to artificial intelligence.
S.3957, the NSF AI Education Act of 2026, has been introduced in the Senate and referred to committee. This bill aims to establish National Science Foundation programs for AI education and professional development, addressing long-term talent shortages in the AI sector. While it outlines policy, it does not specify direct funding amounts or immediate appropriations, making its immediate market impact limited.
AI Grand Challenges Act of 2026
The AI Grand Challenges Act of 2026 (S.3809) has been introduced in the Senate and referred to committee. This bill authorizes the National Science Foundation to establish a competitive prize program for AI research and development across various sectors, including national security, health, and energy, but does not appropriate funds. While the bill signals potential future government investment in AI, its early legislative stage and lack of direct funding appropriation mean immediate market impact is limited.
To prohibit a person from making a misleading recycled content claim in advertising, marketing, selling, or offering for sale a product to a consumer, and for other purposes.
HR7502, currently in the early stages of the legislative process, proposes a federal standard for 'recycled content' claims, which would increase compliance and operational costs for consumer goods and packaging manufacturers. Companies making unsubstantiated claims face Federal Trade Commission enforcement actions, leading to increased legal and operational expenses. This bill directly impacts profitability for companies relying on recycled content claims in their marketing.
Information Quality Assurance Act of 2025
The Information Quality Assurance Act of 2025 (HR6329) is in an early legislative stage, requiring federal agencies to update data quality guidelines. If enacted, this bill would increase demand for information management and data quality services from federal agencies, potentially benefiting technology companies like $IBM, $ACN, $MSTR, and $ORCL. Recent market performance for these companies shows mixed results, with 7-day gains for $IBM and $MSTR, and 7-day declines for $ACN and $ORCL, while all four show 30-day declines.
To amend the National Quantum Initiative Act to make certain additions relating to quantum modeling and simulation, and for other purposes.
HR7749, the "Quantum in Practice Act," has been introduced in the House and referred to committee. This bill expands the National Quantum Initiative Act to include quantum modeling and simulation, signaling a future federal focus on practical quantum applications without authorizing direct funding. Companies with established quantum research divisions may benefit from this policy direction.
Dietary Supplement Listing Act of 2026
The Dietary Supplement Listing Act of 2026, S.3677, mandates pre-market listing for dietary supplements, increasing regulatory burden and compliance costs. This legislation is in its early stages, having been introduced in the Senate and referred to the Committee on Health, Education, Labor, and Pensions on January 15, 2026. The bill is expected to consolidate the market, benefiting larger, established consumer goods and healthcare companies while pressuring smaller, independent supplement manufacturers.
Taiwan Energy Security and Anti-Embargo Act of 2026
The Taiwan Energy Security and Anti-Embargo Act of 2026, S.2722, has advanced to the Senate Legislative Calendar, indicating increased momentum for U.S. LNG exports to Taiwan and enhanced energy infrastructure. This bill directly benefits U.S. LNG producers and pipeline operators by promoting exports, while strengthening Taiwan's critical semiconductor industry through energy security. Recent market data shows mixed performance for related companies, with $LNG up 13.83% over 30 days but down 3.27% over 7 days, and $TSM up 7.98% over 7 days.
Advanced Weather Model Computing Development Act
The Advanced Weather Model Computing Development Act (S.3854) has been introduced in the Senate and referred to committee. This bill directs collaborative research between the Department of Energy and NOAA for advanced weather models, creating potential long-term contract opportunities for high-performance computing hardware, software, and cloud services providers. While the bill does not authorize specific funding amounts, it establishes a framework for future demand in advanced computing solutions.
Small Business Artificial Intelligence Training Act of 2026
The Small Business Artificial Intelligence Training Act of 2026, S.3888, has been introduced in the Senate and referred to the Committee on Commerce, Science, and Transportation. This bill aims to create AI training resources for small businesses, potentially increasing demand for AI-powered tools and services. The bill is in its early stages and does not specify an explicit funding amount.
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.